Paper214439
Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.
Weisgraber KH and 2 others. J Biol Chem, 1978. Cited by 567 papers, by iCite.
Cite this record
ConductScience Library. Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. Papers, record 214439. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/214439
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibroblasts | Major topic |
| Lipoproteins, LDL | Major topic |
| Lysine | Major topic |
| Receptors, Drug | Major topic |
| Amino Acids | |
| Animals | |
| Cell Membrane | |
| Dogs | |
| Humans | |
| Kinetics | |
| Protein Binding |
Source PubMed
Cited by110
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 567 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42241510 | Century of Progress on the Structure of APOB-100 in Atherogenic Lipoproteins. | Circ Res | 2026 | https://conductscience.org/library/papers/42241510 | PubMed |
| 38035276 | Treatment of Parkinson's disease with biologics that penetrate the blood-brain barrier via receptor-mediated transport. | Front Aging Neurosci | 2023 | https://conductscience.org/library/papers/38035276 | PubMed |
| 35227517 | Avenues for post-translational protein modification prevention and therapy. | Mol Aspects Med | 2022 | https://conductscience.org/library/papers/35227517 | PubMed |
| 34638916 | Impact of Posttranslational Modification in Pathogenesis of Rheumatoid Arthritis: Focusing on Citrullination, Carbamylation, and Acetylation. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34638916 | PubMed |
| 33930462 | Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism. | J Biol Chem | 2021 | https://conductscience.org/library/papers/33930462 | PubMed |
| 32011179 | Association of rheumatoid arthritis disease activity and antibodies to periodontal bacteria with serum lipoprotein profile in drug naive patients. | Ann Med | 2020 | https://conductscience.org/library/papers/32011179 | PubMed |
| 31792055 | High-affinity binding of plasminogen-activator inhibitor 1 complexes to LDL receptor-related protein 1 requires lysines 80, 88, and 207. | J Biol Chem | 2020 | https://conductscience.org/library/papers/31792055 | PubMed |
| 31202913 | Modeling Alzheimer's disease with human iPS cells: advancements, lessons, and applications. | Neurobiol Dis | 2019 | https://conductscience.org/library/papers/31202913 | PubMed |
| 30781581 | The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30781581 | PubMed |
| 30463987 | Cell-associated heparin-like molecules modulate the ability of LDL to regulate PCSK9 uptake. | J Lipid Res | 2019 | https://conductscience.org/library/papers/30463987 | PubMed |
| 29592798 | Comparative investigation on the sizes and scavenger receptor binding of human native and modified lipoprotein particles with atomic force microscopy. | J Nanobiotechnology | 2018 | https://conductscience.org/library/papers/29592798 | PubMed |
| 28970916 | Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma. | Chem Sci | 2017 | https://conductscience.org/library/papers/28970916 | PubMed |
| 28848693 | Acetylation of N-terminus and two internal amino acids is dispensable for degradation of a protein that aberrantly engages the endoplasmic reticulum translocon. | PeerJ | 2017 | https://conductscience.org/library/papers/28848693 | PubMed |
| 28570535 | Visualization and Quantitative Analysis of Embryonic Angiogenesis in Xenopus tropicalis. | J Vis Exp | 2017 | https://conductscience.org/library/papers/28570535 | PubMed |
| 26642365 | Serum amyloid A impairs the antiinflammatory properties of HDL. | J Clin Invest | 2016 | https://conductscience.org/library/papers/26642365 | PubMed |
| 26596774 | Local false discovery rate estimation using feature reliability in LC/MS metabolomics data. | Sci Rep | 2015 | https://conductscience.org/library/papers/26596774 | PubMed |
| 25037561 | Protein carbamylation in kidney disease: pathogenesis and clinical implications. | Am J Kidney Dis | 2014 | https://conductscience.org/library/papers/25037561 | PubMed |
| 24363709 | Evalution of in vitro effect of flavonoids on human low-density lipoprotein carbamylation. | Iran J Pharm Res | 2010 | https://conductscience.org/library/papers/24363709 | PubMed |
| 24325674 | Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry. | Biochemistry | 2014 | https://conductscience.org/library/papers/24325674 | PubMed |
| 24213822 | Metabolism of low density lipoproteins in rainbow trout. | Fish Physiol Biochem | 1992 | https://conductscience.org/library/papers/24213822 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/214439
GET https://conductscience.org/api/papers/v1/214439/cited_by?page=2